Trial Profile
A phase III trial to evaluate the safety and efficacy of specific immunotherapy, recombinant idiotype conjugated to KLH with GM-CSF, compared to non-specific immunotherapy, KLH with GM-CSF, in patients with follicular non-Hodgkin's lymphoma
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs B cell lymphoma vaccine (Primary) ; Cyclophosphamide; Keyhole limpet haemocyanin; Prednisone; Vincristine
- Indications Follicular lymphoma
- Focus Registrational; Therapeutic Use
- Sponsors Genitope Corporation
- 09 Jul 2007 New trial record.